StonvexLoading…
StonvexStonvexStonvexCore line items from ECL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2024 2024-09-30 | Annual 2024 2024-06-30 |
|---|---|---|---|---|
Revenue | $16.08B | $15.74B | $4.00B | $3.99B |
Operating Income | $2.74B | $2.80B | $1.04B | $656.90M |
Net Income | $2.08B | $2.11B | Not available | Not available |
EPS (Diluted) | $7.28 | $7.37 | $2.58 | $1.71 |
Total Assets | $24.70B | $22.39B | Not available | Not available |
Total Liabilities | $14.89B | $13.60B | Not available | Not available |
Cash & Equivalents | $646.20M | $1.26B | Not available | Not available |
Free Cash Flow OCF − CapEx | $1.90B | $1.82B | Not available | Not available |
Shares Outstanding | 282.00M | 283.40M | 286.00M | 287.00M |